Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Plantar Fasciitis Randomized Clinical Control Trial

University of Pennsylvania · NCT03231150

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
62
US sites recruiting
1
Study start
March 28, 2017
Record last updated
October 10, 2025

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The primary aim of this clinical experiment is to compare, in terms of pain relief measured using the 10-cm visual analog scale (VAS) pain score (5-7), the clinical results of ultrasound-guided injection (USGI) versus anatomic topography-guided injection (ATGI) of corticosteroid for the treatment of proximal PF. Secondary aims will be to compare foot-related quality of life, as measured using the Foot Function Index (FFI)and the Bristol Foot Score (BFS), between the injection groups, and also to compare the pre-injection to late-term post-injection thickness of the plantar fascia as measured in the nested USGI group.

Being studied: Local Steroid Injection into the plantar heel; Ultrasound Guided Injection; Anatomical Guided injection

Conditions: Plantar Fascitis

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Pain on palpation along the proximal plantar fascia with or without radiographic evidence of a plantar calcaneal bone spur
  • ≥18 years of age
  • Male or non-pregnant female of any ethnicity or race
  • Active, former or non smoker
  • With or without peripheral vascular disease without lower extremity intermittent claudication or rest pain
  • With or without diabetes mellitus without polyneuropathy
  • With or without collagen vascular disease without lower extremity wound formation.

Exclusion Criteria

  • Known drug or alcohol dependence
  • Chronic pain syndrome or lumbosacral radiculitis
  • Neurological condition that requires the use of analgesic medications or anti-seizure or neuroleptic medications
  • Peripheral vascular disease that results in rest pain or intermittent claudication or venous stasis ulceration
  • Calcaneal stress fracture or show evidence of a foreign body or tumor of the affected heel as viewed radiographically
  • Pregnant females
  • Known allergy to any of the components of the injection therapy
  • Previously suffered a rupture or surgery of the plantar fascia within the 5 years preceding participation in the investigation
  • Existing or prior osteomyelitis of the involved calcaneus
  • Unable to consent to participation in clinical research or currently be involved in another clinical investigation.

Recruiting US locations

  • Penn Presbyterian Medical Center

    Philadelphia, PA 19104

    Site contact: Donald S Malay, DPM · 484-844-0755 · malaydsm@gmail.com

Study contacts (from the official record)

  • Donald S Malay, DPM · 4848440755 · malaydsm@gmail.com
  • Hye R Kim, DPM · 443-765-6588 · hearin86@gmail.com
Plantar Fasciitis Randomized Clinical Control Trial (NCT03231150) | Bored Studies